Similar Stories to Merck Drug Shows Improved Odds For Melanoma Patients on Bing News

Merck’s new cancer drug Keytruda improved the survival odds of patients with the skin cancer melanoma compared with Bristol-Myers Squibb’s Yervoy, in the first head-to-head study of a new wave of drugs that harness the body’s immune system to destroy tumors

Topics:  keytruda   bristol-myers squibb s yervoy   merck   drug   improved   odds   melanoma   patients   cancer   
BING NEWS:
  • Personalized mRNA vaccines: A new approach in melanoma treatment
    A personalized mRNA vaccine to treat melanoma has now reached late-stage trials in the UK. This is just the latest step in improving the cure rate of cancer.
    05/4/2024 - 3:50 am | View Link
  • Two-punch treatment delivers blood cancer knockout: Study shows drug combo eradicates cancer cells in lab-based tests
    The WEHI research team paired venetoclax, a current standard-of-care anti-cancer drug for AML, with a STING agonist, an emerging class of immunotherapy drugs. Venetoclax was based on a landmark ...
    04/30/2024 - 1:00 pm | View Link
  • A cheap drug may slow down aging. A study will determine if it works
    In addition, there's research pointing to improved cardiovascular outcomes ... any negative side effects. Research shows a small percentage of people who take metformin experience GI distress that ...
    04/21/2024 - 10:01 pm | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More News